Bing R J, Sarma J S, Fischer R, Ikeda S
Adv Exp Med Biol. 1976;67(00):419-435. doi: 10.1007/978-1-4614-4618-7_25.
Experiments have been described dealing with lipid synthesis and cholesterol uptake in perfused human and pig coronary arteries, rabbit aortas, and with the inhibitory effect of 7-ketocholesterol on cholesterol uptake in these preparations and in rabbits in vivo. Human and pig coronary arteries failed to synthesize cholesterol in vitro. 7-ketocholesterol inhibited cholesterol uptake in human coronary arteries and aortas of pigs and rabbits in vitro and by rabbit aortas in vivo. The inhibitory effect in vivo could only be shown after repeated i.v. injections of 7-ketocholesterol after solubilizing the steroid with bile sale (Na-glycocholate). Although 7-ketocholesterol was absorbed from the G.I. tract, gastric feeding of the bile salt steroid complex was ineffective, probably because of inadequate blood levels of 7-ketocholesterol achieved. The metabolic fate of 7-ketocholesterol and the nature of its effect on cholesterol are discussed. It is not likely that inhibition of HMG-CoA reductase is responsible for the inhibition of cholesterol uptake. The possibility was discussed that both cholesterol and 7-ketocholesterol actively compete for identical and specific binding sites or that an increase in 7-ketocholesterol in plasma leads to an increase in intracellular concentrations of this steroid thus inhibiting cholesterol transfer across the cell membrane. However definite conclusions on the nature of inhibition must await further experimentation.
已描述了一些实验,涉及灌注的人及猪冠状动脉、兔主动脉中的脂质合成和胆固醇摄取,以及7-酮胆固醇对这些制剂和体内兔胆固醇摄取的抑制作用。人及猪冠状动脉在体外不能合成胆固醇。7-酮胆固醇在体外抑制人冠状动脉以及猪和兔主动脉中的胆固醇摄取,在体内抑制兔主动脉中的胆固醇摄取。只有在用胆汁盐(甘氨胆酸钠)溶解类固醇后经静脉反复注射7-酮胆固醇,才能在体内显示出抑制作用。尽管7-酮胆固醇可从胃肠道吸收,但经胃给予胆汁盐类固醇复合物无效,可能是因为所达到的7-酮胆固醇血药浓度不足。讨论了7-酮胆固醇的代谢命运及其对胆固醇作用的性质。HMG-CoA还原酶的抑制不太可能是胆固醇摄取受抑制的原因。讨论了胆固醇和7-酮胆固醇可能积极竞争相同的特异性结合位点,或者血浆中7-酮胆固醇的增加导致该类固醇细胞内浓度升高,从而抑制胆固醇跨细胞膜转运的可能性。然而,关于抑制性质的确切结论必须等待进一步实验。